Working together across international boundaries: Improving the primary-secondary care network

European Journal of Gastroenterology and Hepatology, Supplement

Volumn 13, Issue 2, 2001, Pages

  Hungin, P ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Dyspepsia; Guidelines; International; Primary care; Secondary care

Indexed keywords

CONFERENCE PAPER; DYSPEPSIA; ECONOMIC ASPECT; GENERAL PRACTITIONER; HEALTH CARE; HEALTH SERVICE; HUMAN; INTERNATIONAL COOPERATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; ARTICLE; DRUG ANTAGONISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; MICROBIOLOGY; GASTROENTEROLOGY; GENERAL PRACTICE;

PROTON PUMP; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

DYSPEPSIA; GUIDELINE ADHERENCE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERNATIONAL COOPERATION; PRACTICE GUIDELINES; PROTON PUMPS;

EID: 0034812058     PISSN: 09699163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Dyspepsia in England and Scotland
2. Factors affecting the decision to consult with dyspepsia: Comparison of consulters and non-consulters
3. Systematic review and economic evaluation of H. pylori eradication treatment for non-ulcer dyspepsia
4. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection
5. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: An Asian multicentre double-blind randomized placebo controlled study
6. Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer
7. Prospective double-blind randomized placebo-controlled study comparing two lansoprazole-based triple therapy and one dual therapy for Helicobacter pylori (HP)-related duodenal ulcer (DU): An Asian multicenter study
8. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori
9. One week of lansroprazole, clarithromycin and metronidazole eradicates Helicobacter pylori
10. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori
11. Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: Testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication
12. One week triple therapy for Helicobacter pylori: A multicentre comparative study
13. Proton pump inhibitor triple therapies in the eradication of Helicobacter pylori in Malaysian patients
14. Treatment of Helicobacter pylori infection in clinical practice in the United States: Results from 224 patients
15. An evidence-based approach to the management of uninvestigated dyspepsia in the era of H. pylori
16. Ethnic differences in gastro-oesophageal reflux disease
17. Management of Helicobacter pylori-related gastrointestinal disease by general practitioners in Italy
18. Helicobacter pylori serology and the management of young dyspeptics: A UK survey of gastroenterologists and general practitioners with an interest in gastroenterology